ен може да се обмисли намаляване на дневната доза до 7, 5 mg, основавайки се на
Severe hepatic impairment The use of fondaparinux should be considered with caution because of an increased risk of bleeding due to a deficiency of coagulation factors in patients with severe hepatic impairment (see section 4.2). ct du